Cambridge VIP의 제24회 연차
Medtech MVP Venture & Partnering Conference
Medtech MVP Venture & Partnering 컨퍼런스
Investing in Medtech's Future through Insight and Innovation Sharing
인사이트와 혁신 공유를 통해 MedTech의 미래에 투자
2025년 6월 16일 - 17일
인기가 높은 제24회 연차 Medtech MVP Venture & Partnering 컨퍼런스에서는 업계의 미래를 담당하는 톱레벨의 MedTech 이노베이터·투자자·경영진이 모입니다. 이 서밋에서는 솔직한 패널 디스커션, 파이어사이드 챗, 타운홀 포럼, 풍부한 네트워킹 시간을 제공하며, 자금조달, 출구 전략, 규제 가이던스, 임상시험 디자인, 최신 의료기기 기술의 전망 등 시의적절한 문제를 심도 있게 다룹니다. 다양한 경험이 풍부한 리더에 의한 인사이트와 실천적인 네트워킹에 의해 Medtech MVP는 실용적인 전략을 제공하며, 혁신을 추진하는 인맥을 형성합니다.
올해는 새로운 행정부 하에서 중소기업의 거시경제, 신규 기술의 피치 콘테스트와 기업 쇼케이스, 자금조달, M&A vs. IPO 논쟁, 신경 자극의 진보, 소프트웨어와 하드웨어의 컨버전스, 효과적인 임상시험 디자인, MedTech 조직에서 AI/Gen AI의 활용 방법, 규제 가이던스, 인생을 바꾸는 의료기기를 소개하는 환자 체험담 등의 토픽에 초점을 맞춥니다. 이 특별한 이벤트에서 선도적인 MedTech 전문가가 한자리에 모여 의견 공유와 네트워킹을 통해 업계를 전진시킵니다.
Monday, June 16
Registration Open
Organizer's Welcome Remarks
Successfully Scaling and Commercializing a New Medtech Product
Successfully scaling a MedTech innovation requires strategic growth, regulatory expertise, and strong industry partnerships. This panel brings together experts to discuss key commercialization challenges, from securing investment to navigating FDA approval and accelerating market entry. Gain actionable insights to bring your medical device to market and drive success.
Avio Medtech Pitch Contest
Frank Jaskulke, Vice President, Sales & Business Development, Avio Medtech
Join us for the Avio Medtech Pitch Contest, where the top finalists will present their innovative solutions to a panel of expert judges in a tightly scheduled showdown. Experience back-to-back pitches followed by engaging Q&A sessions, leading up to the highly anticipated announcement of the winner. Don't miss this electrifying finale, filled with groundbreaking ideas and insights into the future of medical technology.
Transition to Breakout Discussions
BREAKOUT DISCUSSIONS
When Reimbursement Talks, People Listen: Optimizing Success and Avoiding Common RoadblocksReimbursement is the key factor in commercialization success. We will focus on the keys to optimizing successful reimbursement strategies and how to avoid common roadblocks that can slow adoption and concern investors.
Breakout Discussion (Opportunity Available)
Networking Welcome Reception
Close of Day
Tuesday, June 17
Registration and Morning Coffee
Organizer's Welcome Remarks
Healthcare Investments and Exits-Q1’25 Update and 2025 Outlook
Innovator Award Introduction
Late-Stage Investor Panel: What’s the Current Pulse on IPOs and M&A?
David Lewis, Managing Partner, Gilmartin Capital
As market dynamics shift, late-stage investors are reevaluating IPO and M&A strategies. This panel brings together industry experts to discuss the current investment landscape, key trends in public offerings, and evolving acquisition opportunities. Gain insights into what investors are looking for, how market conditions impact exit strategies, and what it takes to navigate today’s funding climate successfully.
Networking Coffee Break (Sponsorship Opportunity Available)
BREAKOUT DISCUSSIONS
Breakout DiscussionEvidence Development Challenges Posed by FDA and PayersThis session will focus on key differences in how FDA and payers evaluate the performance of medical technologies through their unique lenses. For emerging technologies in particular, widespread payer coverage routinely lags product approval. Tailoring a comprehensive evidence plan to address the needs of both stakeholders can help shorten this gap.
Breakout DiscussionLessons Learned and Future Advice for Medtech IPO NavigationLearn about the important considerations to follow from an expert panel across public and private medtech as they navigated/navigate/will navigate the world of successful public capital raising. Join Annie Wernig from J.P. Morgan's Healthcare Investment Bank, Kevin Hykes, President and CEO of CVRx, Mike Blue, CEO of Histosonics, and Mike Kujak, President and CEO of Francis Medical as they discuss this important topic.
Breakout Discussion (Opportunity Available)
Transition to General Session
PANEL DISCUSSION:Approaching Strategic Partners: Considerations for Corporate Venture CapitalJ.P. Peltier, Global Head, Healthcare, Piper Sandler
Securing the right strategic partner can accelerate growth, but engaging with corporate venture capital (CVC) requires a tailored approach. This panel explores what CVCs look for in potential investments, how to align with corporate priorities, and key considerations for structuring partnerships. Industry leaders will share strategies for navigating the CVC landscape and positioning your venture for successful collaboration.
Networking Lunch (Sponsorship Opportunity Available)
Introduction to Keynote Speaker Sponsored Presentation (Opportunity Available)
Technology Showcase: Sponsored Presentation (Opportunity Available)
Critical Insights for Entrepreneurs & Investors: How Hospitals & ASCs Evaluate New Medical Devices and Cost-Benefit Decisions
Karen Ruszkoski, Vice President, Market Access and Reimbursement, Volta
Hospitals and ambulatory surgery centers (ASCs) face increasing pressure to balance innovation with cost efficiency when evaluating new medical devices. This panel will provide critical insights into how these institutions assess new technologies, weigh clinical and financial benefits, and make purchasing decisions. Entrepreneurs and investors will gain a deeper understanding of the key factors driving adoption, helping them better position their innovations for success in today’s value-driven healthcare landscape.
BREAKOUT ROUNDTABLE DISCUSSIONS & NETWORKING REFRESHMENT BREAK
Ask the Pros: DuVal & AssociatesThis roundtable provides YOU the opportunity to direct the discussion with professionals at DuVal & Associates. Ask questions about FDA's regulatory process, overcoming submission obstacles, strategies for evidence development, and how to be appropriately aggressive yet compliant in sales and marketing practices under the Food, Drug & Cosmetic Act.
Ask the Reimbursement Experts: What Keeps You Up at Night?Reimbursement is the key factor in commercialization success. We will focus on the keys to optimizing successful reimbursement strategies and how to avoid common roadblocks that can slow adoption and concern investors.
Creative and Successful Approaches for Obtaining Reimbursement Approval
Morgan Evans, Founder & CEO, Agitated Solutions
Securing reimbursement approval is a critical step in the commercialization of new medical technologies, yet the process is complex and ever-evolving. This panel will explore innovative and proven strategies for obtaining coverage, coding, and payment from payers. Experts will share real-world insights on navigating regulatory hurdles, demonstrating value to insurers, and accelerating market adoption through effective reimbursement strategies.
The Next Generation of Neurostimulation Tech: Exploring Brain-Computer Interfaces in MedTech
Juan-Pablo Mas, Partner, Action Potential VC
Brain-computer interfaces (BCIs) are revolutionizing neurostimulation, opening new frontiers in treating neurological disorders and enhancing human capabilities. This panel brings together industry leaders, researchers, and investors to explore the latest advancements in BCI technology, its clinical applications, and the challenges of commercialization. Discover how cutting-edge innovation is shaping the future of MedTech and what it takes to bring next-generation neurostimulation devices to market.
Closing Networking Reception (Sponsorship Opportunity Available)
Close of Summit
* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.